"Increased reimbursement..." I sure hope that means Brilacidin won't face the same political outcry as Gilead's Sovaldi pricing did. But I won't count on it. A lot of people (here as elsewhere in the world) think drug development is a risk-free pursuit, a "game" to rig, and public property.
We'll find out with a successful B. A nice fear to have, I suppose.
News 
Market Data 
Discover 
